Biomea Fusion

BMEANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$91.330 M

$1.26 +0.80%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$61.8M

Loss-making

Shares outstanding

72,483,852

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#308Aldeyra TherapeuticsALDX$93.5M
#309Heron TherapeuticsHRTX$92.9M
#310Biomea FusionBMEA$91.3M
#311Neonc TechnologiesNTHI$90.8M
#312Zhengye BiotechnologyZYBT$89.6M

Where these numbers come from

Share counts and financials for Biomea Fusion are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.